UY27365A1 - Vacuna de mycoplasma bovis y métodos para reducir la neumonía en animales - Google Patents
Vacuna de mycoplasma bovis y métodos para reducir la neumonía en animalesInfo
- Publication number
- UY27365A1 UY27365A1 UY27365A UY27365A UY27365A1 UY 27365 A1 UY27365 A1 UY 27365A1 UY 27365 A UY27365 A UY 27365A UY 27365 A UY27365 A UY 27365A UY 27365 A1 UY27365 A1 UY 27365A1
- Authority
- UY
- Uruguay
- Prior art keywords
- mycoplasma bovis
- vaccine
- methods
- animals
- vaccines
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 6
- 241001138504 Mycoplasma bovis Species 0.000 title abstract 5
- 241001465754 Metazoa Species 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 206010035664 Pneumonia Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- 108010041986 DNA Vaccines Proteins 0.000 abstract 1
- 229940021995 DNA vaccine Drugs 0.000 abstract 1
- 108700001237 Nucleic Acid-Based Vaccines Proteins 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 229940023146 nucleic acid vaccine Drugs 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 229940031626 subunit vaccine Drugs 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La invención: a) refiere a vacunas de Mycoplasma bovis y procedimentos para tratar o prevenir enfermedad o trastorno en un animal causado por infección con Mycoplasma bovis, administrando al animal una cantidad efectiva de una vacuna de Mycoplasma bovis. La misma puede ser una preparación de células totales o parciales inactivas o vivas modificadas, una vacuna de subunidades, o una vacuna de ácido nucleico o ADN. La vacuna de Myclopasma bovis administrada de acuerdo con la presente se puede producir por síntesis o de manera recombinante. b) refiere a vacunas de combinación, procedimientos para la preparación de vacunas de Mycoplasma bovis y kits.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30263801P | 2001-07-02 | 2001-07-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY27365A1 true UY27365A1 (es) | 2003-04-30 |
Family
ID=23168600
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY27365A UY27365A1 (es) | 2001-07-02 | 2002-07-01 | Vacuna de mycoplasma bovis y métodos para reducir la neumonía en animales |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US20030147914A1 (es) |
| EP (1) | EP1401488A1 (es) |
| JP (1) | JP2004536106A (es) |
| KR (1) | KR20040030783A (es) |
| CN (1) | CN1522152A (es) |
| AP (1) | AP2002002568A0 (es) |
| AR (1) | AR036125A1 (es) |
| BG (1) | BG108496A (es) |
| BR (1) | BR0210798A (es) |
| CA (1) | CA2452580A1 (es) |
| CZ (1) | CZ20033465A3 (es) |
| EA (1) | EA200301324A1 (es) |
| GT (1) | GT200200139A (es) |
| HN (1) | HN2002000162A (es) |
| HR (1) | HRP20031078A2 (es) |
| HU (1) | HUP0501188A2 (es) |
| IL (1) | IL159516A0 (es) |
| IS (1) | IS7078A (es) |
| MA (1) | MA27048A1 (es) |
| MX (1) | MXPA03011815A (es) |
| NO (1) | NO20035767L (es) |
| OA (1) | OA12640A (es) |
| PA (1) | PA8549801A1 (es) |
| PE (1) | PE20030239A1 (es) |
| PL (1) | PL373891A1 (es) |
| SK (1) | SK15802003A3 (es) |
| TN (1) | TNSN03154A1 (es) |
| UY (1) | UY27365A1 (es) |
| WO (1) | WO2003004052A1 (es) |
| YU (1) | YU102103A (es) |
| ZA (1) | ZA200309747B (es) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7179473B2 (en) | 1998-06-05 | 2007-02-20 | Boehringer Ingelheim Vetmedica Gmbh | Attenuated pestiviruses |
| US7135561B2 (en) | 2001-09-06 | 2006-11-14 | Boehringer Ingelheim Vetmedica Gmbh | Infectious bovine viral diarrhea virus clone |
| US7279166B2 (en) * | 2001-12-12 | 2007-10-09 | Virginia Tech Intellectual Properties, Inc. | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
| SE0301436D0 (sv) * | 2003-05-16 | 2003-05-16 | Joakim Westberg | New proteins |
| US7572455B2 (en) * | 2004-05-19 | 2009-08-11 | Boehringer Ingelheim Vetmedica Gmbh | Vaccine comprising an attenuated pestivirus |
| UY29915A1 (es) * | 2005-11-15 | 2007-06-29 | Boehringer Ingelheim Vetmed | Vacuna combinada que comprende un virus atenuado de la diarrea viral bovina |
| US20110059437A1 (en) * | 2006-09-07 | 2011-03-10 | Boehringer Ingelheim Vetmedica, Inc. | Pcr-based genotyping |
| JP5550341B2 (ja) | 2006-09-11 | 2014-07-16 | ゾエティス・ピー・エルエルシー | 熱処理バクテリンおよびそのような熱処理バクテリンから調製された乳剤ワクチン |
| CL2008003202A1 (es) * | 2007-10-29 | 2009-11-27 | Boehringer Ingelheim Vetmedica Inc | Composicion inmunogenica que comprende bacterias vivas de mycoplasma bovis atenuada avirulenta. |
| UY31930A (es) * | 2008-06-25 | 2010-01-29 | Boheringer Ingelheim Pharma Kg | Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante |
| CA2729080C (en) * | 2008-07-03 | 2018-09-11 | Ricardo Rosenbusch | Cattle vaccines |
| WO2010051210A1 (en) * | 2008-10-31 | 2010-05-06 | Boehringer Ingelheim Vetmedica, Inc. | Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition |
| US8846054B2 (en) * | 2009-01-09 | 2014-09-30 | Boehringer Ingelheim Vetmedica, Inc. | Method of treating pregnant cows and/or heifers |
| UY32570A (es) * | 2009-04-24 | 2010-11-30 | Boehringer Ingelheim Vetmed | Vacuna viva modificada de mycoplasma bovis mejorada |
| JP5968622B2 (ja) | 2009-06-04 | 2016-08-10 | 国立感染症研究所長 | マイコプラズマ感染症用ワクチン |
| CN102220263B (zh) * | 2011-05-06 | 2012-10-03 | 华中农业大学 | 一种牛支原体致弱菌株及其应用 |
| SG11201505089YA (en) | 2012-12-28 | 2015-07-30 | Boehringer Ingelheim Vetmed | Method of making a mycoplasma vaccine |
| CN104857509A (zh) * | 2015-06-02 | 2015-08-26 | 福清市默克兽医院 | 牛支原体肺炎组织灭活疫苗的制备方法、配方及使用方法 |
| BR112018002919B1 (pt) | 2015-08-14 | 2024-02-27 | Zoetis Services Llc | Composição imunogênica eficaz compreendendo uma cepa de mycoplasma bovis e usos da mesma para prevenção de doenças causadas por mycoplasma bovis |
| CN105441368B (zh) * | 2016-01-19 | 2019-01-01 | 福清市默克兽医院 | 一株牛支原体及其应用 |
| CN106929452B (zh) * | 2017-04-11 | 2020-06-12 | 河南省农业科学院畜牧兽医研究所 | 一株牛支原体及其应用 |
| CN109022314B (zh) * | 2018-08-06 | 2021-08-13 | 北京华夏兴洋生物科技有限公司 | 一株牛支原体及其在疫苗研制中的应用 |
| CN110338138B (zh) * | 2019-06-19 | 2021-04-06 | 山东省农业科学院奶牛研究中心 | 一种牛支原体感染豚鼠的动物模型构建方法及其应用 |
| CN112301041B (zh) * | 2020-10-09 | 2022-05-24 | 华中农业大学 | 牛支原体p21蛋白及其应用 |
| CN113546162B (zh) * | 2021-05-31 | 2023-07-18 | 江苏省农业科学院 | 一种支原体疫苗及其制备方法 |
| CN113604492B (zh) * | 2021-09-10 | 2023-07-07 | 苏州世诺生物技术有限公司 | 融合基因、融合蛋白及制备方法和牛支原体亚单位疫苗 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5565205A (en) * | 1990-08-16 | 1996-10-15 | Solvay Animal Health, Inc. | Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof |
| EP1229929A2 (en) * | 1999-11-08 | 2002-08-14 | Biomune | VACCINES FOR i MYCOPLASMA BOVIS /i AND METHODS OF USE |
| DE29921392U1 (de) * | 1999-12-06 | 2000-03-16 | Dr. Felgenträger & Co. Öko-Chem. und Pharma GmbH, 06862 Rodleben | Mykoplasma-bovis-Kombinations-Vakzine für Rinder |
| US6548069B2 (en) * | 2001-02-03 | 2003-04-15 | Hmv Associates, Inc. | Multivalent Mycoplasma bacterin |
-
2002
- 2002-06-20 US US10/177,857 patent/US20030147914A1/en not_active Abandoned
- 2002-06-27 WO PCT/IB2002/002514 patent/WO2003004052A1/en not_active Ceased
- 2002-06-27 HU HU0501188A patent/HUP0501188A2/hu unknown
- 2002-06-27 TN TNPCT/IB2002/002514A patent/TNSN03154A1/fr unknown
- 2002-06-27 SK SK1580-2003A patent/SK15802003A3/sk not_active Application Discontinuation
- 2002-06-27 PL PL02373891A patent/PL373891A1/xx unknown
- 2002-06-27 EA EA200301324A patent/EA200301324A1/ru unknown
- 2002-06-27 MX MXPA03011815A patent/MXPA03011815A/es unknown
- 2002-06-27 OA OA1200300346A patent/OA12640A/en unknown
- 2002-06-27 CA CA002452580A patent/CA2452580A1/en not_active Abandoned
- 2002-06-27 CZ CZ20033465A patent/CZ20033465A3/cs unknown
- 2002-06-27 BR BRPI0210798-8A patent/BR0210798A/pt not_active IP Right Cessation
- 2002-06-27 KR KR10-2004-7000003A patent/KR20040030783A/ko not_active Ceased
- 2002-06-27 YU YU102103A patent/YU102103A/sh unknown
- 2002-06-27 CN CNA028132882A patent/CN1522152A/zh active Pending
- 2002-06-27 HR HR20031078A patent/HRP20031078A2/hr not_active Application Discontinuation
- 2002-06-27 JP JP2003510062A patent/JP2004536106A/ja active Pending
- 2002-06-27 IL IL15951602A patent/IL159516A0/xx unknown
- 2002-06-27 AP APAP/P/2002/002568A patent/AP2002002568A0/en unknown
- 2002-06-27 EP EP02738544A patent/EP1401488A1/en not_active Withdrawn
- 2002-06-28 HN HN2002000162A patent/HN2002000162A/es unknown
- 2002-07-01 PE PE2002000592A patent/PE20030239A1/es not_active Application Discontinuation
- 2002-07-01 UY UY27365A patent/UY27365A1/es not_active Application Discontinuation
- 2002-07-01 AR ARP020102480A patent/AR036125A1/es unknown
- 2002-07-02 PA PA20028549801A patent/PA8549801A1/es unknown
- 2002-07-02 GT GT200200139A patent/GT200200139A/es unknown
-
2003
- 2003-12-15 IS IS7078A patent/IS7078A/is unknown
- 2003-12-17 ZA ZA200309747A patent/ZA200309747B/xx unknown
- 2003-12-22 BG BG108496A patent/BG108496A/xx unknown
- 2003-12-22 NO NO20035767A patent/NO20035767L/no not_active Application Discontinuation
- 2003-12-31 MA MA27469A patent/MA27048A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MA27048A1 (fr) | 2004-12-20 |
| US20030147914A1 (en) | 2003-08-07 |
| BG108496A (en) | 2005-02-28 |
| WO2003004052A1 (en) | 2003-01-16 |
| TNSN03154A1 (fr) | 2005-12-23 |
| IL159516A0 (en) | 2004-06-01 |
| SK15802003A3 (sk) | 2005-01-03 |
| GT200200139A (es) | 2003-02-13 |
| IS7078A (is) | 2003-12-15 |
| JP2004536106A (ja) | 2004-12-02 |
| NO20035767L (no) | 2004-01-30 |
| AP2002002568A0 (en) | 2002-06-30 |
| KR20040030783A (ko) | 2004-04-09 |
| HUP0501188A2 (en) | 2006-05-29 |
| AR036125A1 (es) | 2004-08-11 |
| HRP20031078A2 (en) | 2005-08-31 |
| EA200301324A1 (ru) | 2004-12-30 |
| ZA200309747B (en) | 2005-05-27 |
| CN1522152A (zh) | 2004-08-18 |
| CA2452580A1 (en) | 2003-01-16 |
| HN2002000162A (es) | 2002-09-17 |
| YU102103A (sh) | 2006-05-25 |
| CZ20033465A3 (cs) | 2004-12-15 |
| PA8549801A1 (es) | 2003-09-17 |
| MXPA03011815A (es) | 2004-04-02 |
| EP1401488A1 (en) | 2004-03-31 |
| BR0210798A (pt) | 2006-05-23 |
| PL373891A1 (en) | 2005-09-19 |
| OA12640A (en) | 2006-06-15 |
| PE20030239A1 (es) | 2003-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY27365A1 (es) | Vacuna de mycoplasma bovis y métodos para reducir la neumonía en animales | |
| AR034677A1 (es) | Vacuna de mycoplasma hyopneumoniae y metodos para reducir la neumonia por mycoplasma bovis en el ganado | |
| UY27366A1 (es) | Vacunación en dosis única con mycoplasma hyopneumoniae | |
| BRPI0010612B8 (pt) | vacinas | |
| CY1120015T1 (el) | Μεθοδοι χορηγησης εμβολιων | |
| ES2185762T3 (es) | Vacunas contra la peste. | |
| US11975068B2 (en) | Mesenchymal stem cells as vaccine adjuvants and methods for using the same | |
| CO5611162A2 (es) | Metodos para prevenir enfermedades reproductivas en el ganado vacuno | |
| BRPI0614119B8 (pt) | vacina para imunizar gatos contra calicivírus de felino | |
| Cooke et al. | Cellular adhesive phenomena in apicomplexan parasites of red blood cells | |
| PT777499E (pt) | Vacina viva para tratamento de doencas tumorais | |
| AR036355A1 (es) | Modelo de exposicion a mycoplasma bovis, para evaluar la eficacia de potenciales vacunas | |
| BR0109928A (pt) | Uso de um herpes vìrus atenuado, e, método para estimular uma resposta imune em um indivìduo humano ou animal, ou para tratar ou prevenir uma infecção patogênica ou câncer em um indivìduo humano ou animal | |
| UY26763A1 (es) | Inmunización del ganado lacteo con proteína gapc quimérica contra infección por estreptococo. | |
| MX2023005154A (es) | Nanopartículas codificadas de adn y método de uso de las mismas como una vacuna contra la enfermedad corona virus (covid-19). | |
| AR048671A1 (es) | Procedimiento de vacunacion contra la infeccion testicular por bvdv | |
| JP5865839B2 (ja) | 粘膜アジュバント組成物 | |
| RU2240820C2 (ru) | Средство для профилактики инфекционного кератоконъюнктивита крупного рогатого скота и способ профилактики этого заболевания | |
| CY1116862T1 (el) | Εμβολιασμος μιας δοσης me mycoplasma hyopneumoniae | |
| TH64472A (th) | การให้วัคซีนขนาดยาเดียวที่มี Mycoplasma Hyopneumoniae | |
| RU2000118399A (ru) | Средство для профилактики инфекционного кератоконъюнктивита крупного рогатого скота и способы профилактики этого и других инфекционных заболеваний крупного рогатого скота (варианты) | |
| HN2002000163A (es) | Vacunacion en dosis unica con mycoplasma hyopneumoniae | |
| ES2172482B1 (es) | Adicion de la patente es200100402 "vacuna para la proteccion de perros frente a la leishmania". |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20150826 |